Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool... see more

TSXV:CVM.H - Post Discussion

CVR Medical Corp > NEX listing
View:
Post by Looneytunes on Nov 12, 2022 3:35am

NEX listing

https://apps.tmx.com/TMX/HttpController?GetPage=NEXQuotesViewPage&IsJ2Market=Yes&RowNumber=1&SelectedSymbol=CVM.H&DetailedView=DetailedCompanyInformation&QuoteSymbol_1=CVM&QuoteSymbol_2=&QuoteSymbol_3=&QuoteSymbol_4=&QuoteSymbol_5=&QuoteSymbol_6=&QuoteSymbol_7=&QuoteSymbol_8=&QuoteSymbol_9=&QuoteSymbol_10=&QuoteSymbol_11=&QuoteSymbol_12=
Comment by Abovenbeyond on Nov 12, 2022 1:41pm
What's this?
Comment by Looneytunes on Nov 12, 2022 7:42pm
CVRs listing details on the NEX, hardly surprising they were kicked of the TSX V the details are so far out of date it shows they clearly didn't give a toss about the listing and just used it as a way of screwing money out of unsuspecting investors
Comment by Abovenbeyond on Nov 12, 2022 8:04pm
Weren't they just like 10 trials short from getting fda approval? Why submit to the fda and be a few trials short of required? Can't they just get what they need and submit again.?
Comment by Looneytunes on Nov 13, 2022 12:47pm
Hopefully they will be able to do that, the main problem will be getting the cash to psy for the trials
Comment by woundedknee on Nov 14, 2022 3:28pm
Who would give cash to these crooks? I would have thought someone would have bought this company by now if the CSS is as good as it's touted to be. Total tragedy!!
Comment by Abovenbeyond on Dec 01, 2022 12:00pm
?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities